The Valley Desk

ArticleMolecular therapy : the journal of the American Society of Gene TherapyPublished

Clinical trial results provide the rationale to protect dual HIV-specific T cells with a signaling-defective HIV fusion inhibitor

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Molecular therapy : the journal of the American Society of Gene Therapy
Published
Subject terms
T-Lymphocytes; CD4-Positive T-Lymphocytes; Animals; Humans; HIV-1; HIV Infections; Peptide Fragments; Receptors, CXCR4; HIV Envelope Protein gp41; HIV Fusion Inhibitors; Signal Transduction; Mutation
PubMed ID
41520175
Added to directory
Source checked

Report a correction or request removal